Better, Stronger, Faster: Why Nootropics Will Be Big Business In 2016
Originally published in Forbes By Mike Montgomery Depending on whose numbers you believe, the U.S. supplement industry is either a $12 billion or a $37 billion industry. That’s…
Originally published in Forbes By Mike Montgomery Depending on whose numbers you believe, the U.S. supplement industry is either a $12 billion or a $37 billion industry. That’s…
Originally published in CNBC By Phil Wickham, CEO of Kauffman Fellows For most people, a unicorn is a mythical horse with a pointed horn in a…
Originally published in CNN by Ramphis Castro A recent event at Havana’s Panorama Hotel provided a unique view into the future of Cuba. Some 50…
Originally published in Venture Beat By Phil Wickham, Center for Venture Capital As Mel Brooks said, it’s good to be the king. And Sequoia Capital’s Mike…
Originally published in Entrepreneur By Jonathon Triest Somewhere in that slush pile of pitches on my desk is an original idea and a bio of an…
Originally published on PE Hub By Phil Wickham, Kauffman Fellows Venture capitalists, like the entrepreneurs they finance, never sleep. They are always searching, moving, evolving. The…
Originally published in MarketWatch By Tammi Jantzen Venture capitalists are known for their intellectual curiosity, searching everywhere for new technologies that could change the world. Except…
Originally published in the Boulder Daily Camera By Nancy Stevens Call it “Hippy town hits it big.” That’s my shorthand for the potential for massive…
Originally published by CNBC By Mike McGill The process of selling a company often focuses on historical financial results, but exceptional valuations generally flow to sellers…